A Multicenter, Open-Label, Randomized Study Comparing Efficacy and Safety of S-1 as Single Agent Versus 5-FU Bolus for the Treatment of Patients With Metastatic Pancreatic Cancer Previously Treated With a Gemcitabine-Based Regimen.
Phase of Trial: Phase III
Latest Information Update: 28 May 2016
At a glance
- Drugs Fluorouracil; Gimeracil/oteracil/tegafur
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- 05 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 05 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.